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Over the past 12 months, measles outbreaks have occurred in a number of Australian states.1 The 
source of these infections has been linked to 
travellers returning from measles-endemic 
countries.1 
In 2012, an imported case from Thailand led 
to the largest measles outbreak in New South 
Wales since 1997, with 168 identified cases, 
104 of which were children and adolescents.2 
Of all those affected, only 40 had a history of 
receiving one dose of the measles-mumps-
rubella (MMR) vaccine.2 Ninety-five of the 
remaining 128 cases were greater than one 
year of age with uncertain, or no history of 
MMR vaccination, indicating that they had 
not been vaccinated appropriately for their 
age.2 Interestingly, 32 of these cases reported 
vaccine refusal as the reason for not being 
vaccinated.2 
Active vaccine refusal is a significant issue 
and impediment to achieving universal 
vaccination rates. A parent’s decision to 
refuse vaccination for their children is the 
endpoint of a complex process that is 
influenced by psychological and sociocultural 
determinants.3 It is timely to review these 
determinants and the impact they have on 
MMR vaccine uptake in Australia. 
Australia enjoys high average childhood 
vaccination coverage, but there are areas 
where vaccination rates remain suboptimal.4 
The National Health Performance Authority 
(NHPA) released a report on immunisation 
rates for all Australian children over 2012–13 
at three geographic levels, including 
Medicare Local catchments.4 The report 
indicated that in catchments with large 
populations, a high percentage vaccination 
coverage can conceal a large number of 
under-immunised children.4 For instance, in 
South Western Sydney with an immunisation 
rate of 92.5% at five years of age, 3,400 
children were still not fully immunised.4 This is 
the same area that experienced the measles 
outbreak in 2012.2 Overall, the NHPA report 
revealed that more than 75,000 children in 
Australia remain under-immunised for their 
age.4 This represents a large group of children 
at unnecessary risk of measles infection and 
associated complications such as pneumonia, 
otitis media, encephalitis and death.5 How to 
increase vaccine coverage and reduce this risk 
remains an important challenge.
The risk of disease outbreak can be mitigated 
by ensuring childhood immunisation rates 
are as high as possible. One of the primary 
factors in achieving this is to maintain positive 
attitudes towards childhood vaccination and 
decrease vaccine hesitancy among parents.6 
Vaccine hesitancy is a term that has come 
to define a group of individuals who have 
varying concerns about vaccines and adopt 
behaviours to lessen these concerns.7 A range 
of such behaviours has been described.6,7 
These include parents who have their 
children vaccinated despite being concerned 
about potential consequences of doing so, 
parents who selectively alter their child’s 
vaccination schedule or delay introduction of 
vaccines in the belief that this will avoid some 
kind of harm and those who firmly refuse 
all vaccines.6,7 Such practices contribute to 
regional variation in vaccination coverage, 
reduce local herd immunity and increase the 
possibility of vaccine preventable disease 
outbreaks within the community.6,8,9
The reasons for vaccine hesitancy are diverse 
and issues that contribute to the decision 
process include: the perceived benefit of 
vaccination, trust of information sources, 
concerns over the number of vaccines given 
and possible effects on developing immune 
systems, suboptimal interactions with 
healthcare providers and fears about the 
safety of specific vaccines.3,7,8 Concerns over 
vaccine safety are important to parents and 
typically centre on adverse effects associated 
with the development of significant harm.3,6,10 
The differing harms ascribed to individual 
vaccines share similarities such that they 
are disorders with idiopathic origins that 
share certain epidemiological and societal 
features but have no scientifically proven 
link to vaccination.10 Specifically for the MMR 
vaccine, the purported causal association 
between vaccination and subsequent 
development of autism continues to raise 
concern among parents.3,8,11 This claim has 
dominated and substantially skewed much of 
the debate around issues with vaccine uptake 
and the MMR vaccine in particular. 
The proposed link between MMR vaccination 
and autism gained notoriety following the 
publication of an article by Wakefield and 
12 co-authors in the Lancet in 1998.12 This 
case-series of 12 children suggested that 
there is a temporal association between MMR 
vaccination and the onset of autism and 
gastrointestinal disease.12 The subsequent 
publicity of this claim in the mainstream 
media led to a significant loss of parental 
confidence in the MMR vaccine, most notably 
in the United Kingdom.12,13 However, studies 
into the MMR-autism link conducted after 
the publication of Wakefield’s 1998 article 
have consistently failed to demonstrate any 
evidence to support an association between 
MMR vaccination and autism.12,13 
A large body of scientific evidence now 
exists that strongly indicates that the 
posited link between MMR vaccination and 
the development of autism is false. This is 
supported by a Cochrane review and recent 
meta-analysis, which both found that there 
was no significant association between 
development of autism and exposure 
to the MMR vaccine.13,14 This evidence is 
strengthened by a publication from the 
Institute of Medicine in the United States, 
which reviewed the epidemiological and 
mechanistic evidence for a MMR-autism 
link.5 The expert committee concluded that 
the combined weight of evidence favours 
rejection of a causal association between 
MMR vaccination and the development of 
autism.5 These analyses represent a large 
volume of condensed research that reliably 
dispels the myth that autism is linked to MMR 
vaccination. 
Not only has the scientific literature 
consistently failed to establish an association 
between MMR vaccination and autism, serious 
questions and allegations exist regarding the 
credibility of Wakefield’s original study. An 
investigation by the British General Medical 
Council into the study found Wakefield to 
be guilty of ethical, medical and scientific 
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misconduct in the publication of his 
research.12,14 This finding led the Lancet to fully 
retract the article in 2010.12,14 However, the 
criteria for retraction have been criticised as 
too narrow, being based only on lack of ethics 
approval to conduct the study and issues with 
the referral process of research subjects.12 
Important issues that were not highlighted 
in the retraction include: claims that data 
within the article is fraudulent, with patient 
information being purposefully altered; and 
claims that Wakefield had a financial interest 
in pursuing results that would link MMR 
vaccination to autism.12,14 Ultimately, the 
Lancet’s narrow reasons for retraction allow 
individuals to continue to believe in and 
promote the flawed science contained within 
the article,  leading to a continued presence of 
this issue in the scientific literature and on the 
internet, where vaccine-hesitant parents are 
likely to begin their research.12,15
Unfiltered communication mediums such as 
the internet and social media are frequently 
used by anti-vaccination groups to reach 
wide audiences and influence vaccination 
practices.7,8,16 The Australian Vaccination-
skeptics Network is one such group that 
actively promotes vaccine safety issues to 
parents and continues to support the notion 
that autism is linked to MMR vaccination.15 
Assertions made by these groups can mislead 
parents, who often use the internet as a 
starting point for researching information 
about vaccines.15 The style of communication 
used in these forums is that of narrative and 
parental testimony about vaccine adverse 
effects.3 These parental accounts are seen 
by other parents as honest and without an 
agenda as opposed to official sources of 
vaccine information such as that provided 
by government institutions.3,16 This results 
in the generation of trust in this information 
source among parents and they subsequently 
become misinformed about, and hesitant 
towards, childhood vaccination. 
To counter this requires a proactive response 
on behalf of healthcare providers, who remain 
a trusted source of vaccine information to 
most parents.3,8 The first step in dealing with 
parental concerns obtained from unreliable 
sources is for healthcare providers to clarify 
any misconceptions that they themselves 
may have about vaccine safety. In a study by 
Philips et al.11 it was found that less than half 
of healthcare providers surveyed correctly 
identified that there was no association 
between MMR vaccination and autism. This 
finding is completely at odds with current 
evidence on this issue and demonstrates a 
failure in knowledge that must be corrected.11 
Since the opinion of healthcare providers is 
highly valued by uncertain parents seeking 
information about vaccines they must be 
confident in the safety profile of the vaccines 
they recommend.9 However, as the reasons 
for vaccine hesitancy are diverse, simply 
addressing safety issues is unlikely to result in 
the changes necessary to boost MMR vaccine 
uptake.3,7
Communication between healthcare 
providers and parents is fundamental to 
addressing the concerns that cause vaccine 
hesitancy.3,8,16 Currently the evidence for 
the effectiveness of any one particular 
communication strategy to improve 
vaccination rates is lacking and it is advisable 
to incorporate individualised approaches 
into routine healthcare encounters.17 The 
most widely described approach is one that 
respectfully acknowledges, and seeks to 
address, the concerns that parents have in a 
non-confrontational manner.3,8,9,18 Strategies 
aimed only at correcting common factual 
misconceptions could be counter-productive 
if they do not elicit and address underlying 
parental concerns.18,19 While communication 
efforts on behalf of healthcare providers 
are essential to inform vaccine decision-
making, it is important that there is not an 
over-reliance on this as the only strategy to 
increase MMR vaccination rates; development 
of a multifaceted approach is required.3,8,20 
Multiple strategies implemented at both 
the professional and community level are 
essential for achieving a tailored response 
across the whole population.3,6,20 Initiatives 
at the professional level include those that 
can be used by healthcare providers in 
their daily practice. Providing parents with 
resources that counter anti-vaccination 
messages should be routine and complement 
the communication efforts previously 
discussed.6,17 These include reliable sources 
of vaccine information such as the Immunise 
Australia Program’s booklet, Understanding 
Childhood Immunisation,21 or the National 
Centre for Immunisation Research and 
Surveillance’s website, which provides an 
online MMR decision aid in addition to 
other resources.22 Other strategies that 
have an evidence base in the Australian 
context include recall/reminder systems for 
patients and providers, use of catch-up plans 
for overdue vaccinations, and expanding 
services in hospitals and public settings 
for opportunistic immunisation.11,20 It is 
important to note that these strategies are 
most efficacious when two or more are used 
in combination.20
The main focus for improving MMR vaccine 
uptake at the community level is to develop 
strategies that recognise and target at-risk 
groups and increase demand for vaccination 
across the population.2,20 There are numerous 
groups within the community considered 
to be at-risk for continuing suboptimal 
vaccine coverage.3,20 Those that have been 
identified as posing the greatest risk for 
measles transmission include unvaccinated 
travellers, children and adolescents, and 
people of Pacific Island descent (who were 
over-represented in the 2012 outbreak in 
New South Wales).1,2,20 A universal approach 
cannot be appropriately applied to these 
disparate groups and tailored vaccination 
campaigns in areas with known low 
vaccination rates are required.2,20 More 
broadly, engagement of community leaders 
and media organisations to open channels 
of communication between public health 
authorities and the wider community should 
also be used to increase public awareness and 
demand for vaccination.20,23 
The implementation of these strategies 
requires dialogue between policy makers, 
healthcare providers and the public.9 This 
requires leadership from government so 
that all interested parties can contribute 
to the development of a comprehensive 
strategy. The recently launched Queensland 
Immunisation Strategy 2014–17 provides an 
example of this whereby the Queensland 
State Government aims to strengthen its 
working relationship with key healthcare and 
community stakeholders.24 Bringing these 
groups together and setting clear goals and 
priorities is an important step for increasing 
MMR vaccine uptake and vaccination 
coverage in general. 
Measles outbreaks continue to be a public 
health issue in Australia. This serves as a 
reminder that there is a need for continued 
education on the benefits of vaccination with 
emphasis placed on the safety of the MMR 
vaccine. To be effective, education needs to 
be directed at both healthcare providers and 
parents. The reasons for vaccine hesitancy are 
diverse and an appropriate response needs 
to address the underlying issues. This entails 
healthcare providers being receptive of the 
concerns raised by parents and ensuring that 
reasons for vaccine hesitancy are addressed 
through diligent communication efforts, 
provision of resources to counter anti-
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vaccination sentiment, and strategies that 
provide a safety net to follow-up children 
who miss routine vaccinations. Continued 
monitoring of at-risk groups within the 
community and development of strategies 
to reach and engage these groups are also 
needed. Through these measures it is hoped 
that MMR vaccine uptake can be improved 
and future measles outbreaks in Australia 
prevented.
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Since the announcement of the budget bill on May 13, 2014, Australia’s Coalition Government faced concerted 
criticism over the equity and coherence of 
proposed changes to Medicare, particularly 
regarding the introduction of a co-payment 
for GP consultations, radiology and pathology 
services or, more latterly, reductions in 
Medicare rebates. The current surviving policy 
iteration, effective from 1 July 2015, cuts 
rebates by $5 for non-concessional patients. 
The proposals continue to be debated: the 
Australian Medical Association proposed 
an alternative model designed to protect 
financially vulnerable populations and 
strategic interventions;1 the Labor opposition, 
Greens and minority parties opposed the 
proposal. After failing to secure support in 
the Senate for the legislation, and objections 
to its proposed use of regulation to achieve 
the changes, the Government has re-entered 
dialogue around this proposal. From 1 July 
2015, “for non-concessional patients, the 
Medicare Benefits Schedule (MBS) rebates for 
common GP consultations will be reduced by 
$5 from 1 July 2015. Doctors may choose to 
recoup this amount from the patient through 
an optional co-payment.” 2 Notwithstanding 
the nature of the eventual deal between the 
Government and minor parties, the general 
Coalition drive toward introducing co-
payments for access to primary health care is 
just one important element of a budget that 
had presaged an $8.5 billion cut to the overall 
health budget. 
In this paper we express a number of 
concerns about the impact and wisdom of 
introducing these changes, detailing their 
regressive impact on the less well-off and on 
primary health care more broadly.3
Co-payment is not new to considerations of 
Australian primary care: both major parties 
have proposed co-payments at some point, 
and under Medicare, Australian GPs can 
independently set their fees and require 
a co-payment, although 81.1% of current 
GP services are bulk-billed (DoH. 2014).4 
doi: 10.1111/1753-6405.12348
Proposed changes to Medicare: 
undermining equity and outcomes in 
Australian primary health care?
Owain Williams,1 Allyson Mutch,1 Pamela S. Douglas,2 Frances M. Boyle,1 Peter S. Hill1
1. School of Public Health, University of Queensland
2. Discipline of General Practice, School of Medicine, University of Queensland
Commentary
